Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Thomas Vanicek, Jakob Unterholzner, Rupert Lanzenberger, Angela Naderi-Heiden, Siegfried Kasper & Nicole Praschak-Rieder. (2022) Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder. The World Journal of Biological Psychiatry 23:9, pages 715-718.
Read now
Read now
Hyacinth John & Verinder Sharma. (2009) Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences. The World Journal of Biological Psychiatry 10:4-2, pages 612-615.
Read now
Read now
Adityanjee, Ann Romine, Eric Brown, Paul Thuras, Susanne Lee & S. Charles Schulz. (2008) Quetiapine in Patients with Borderline Personality Disorder: An Open-Label Trial. Annals of Clinical Psychiatry 20:4, pages 219-226.
Read now
Read now
Massimo C Mauri, Lucia S Volonteri, Alessio Fiorentini, Rodolfo Pirola & Silvio R Bareggi. (2007) Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels. Expert Opinion on Pharmacotherapy 8:14, pages 2207-2213.
Read now
Read now
Donald L Rowe. (2007) Off-label prescription of quetiapine in psychiatric disorders. Expert Review of Neurotherapeutics 7:7, pages 841-852.
Read now
Read now
Marianne Goodman, Lucia Vail, Sara West, Antonia New & Larry Siever. (2007) The Pharmacological and Psychological Treatment of Personality Disorders—From Neurobiology to Treatment Strategies. Journal of Family Psychotherapy 17:3-4, pages 53-81.
Read now
Read now
Yves Le Bloc'h, Pierre Baumann, Michael Stigler, Chin B. Eap, Daniele F. Zullino, Yves Le Bloc'h, Pierre Baumann, Michael Stigler, Chin B. Eap & Daniele F. Zullino. (2007) Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study. International Journal of Psychiatry in Clinical Practice 11:2, pages 123-128.
Read now
Read now
Torsten Gruettert & Lars Friege. (2005) Quetiapine in patients with borderline personality disorder and psychosis: a case series. International Journal of Psychiatry in Clinical Practice 9:3, pages 180-186.
Read now
Read now
Articles from other publishers (23)
Charles Timäus, Miriam Meiser, Borwin Bandelow, Kirsten R. Engel, Anne M. Paschke, Jens Wiltfang & Dirk Wedekind. (2019) Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice. BMC Psychiatry 19:1.
Crossref
Crossref
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Birgit A. Völlm, Martin Clarke, Vicenç Tort Herrando, Allan O. Seppänen, Paweł Gosek, Janusz Heitzman & Erik Bulten. (2020) European Psychiatric Association (EPA) guidance on forensic psychiatry: Evidence based assessment and treatment of mentally disordered offenders. European Psychiatry 51, pages 58-73.
Crossref
Crossref
Darcy Brown, Fintan Larkin, Samrat Sengupta, Jose L. Romero-Ureclay, Callum C. Ross, Nitin Gupta, Morris Vinestock & Mrigendra Das. (2014) Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital. CNS Spectrums 19:5, pages 391-402.
Crossref
Crossref
Paul L. Plener & Ulrike M. Schulze. 2014. Non-Suicidal Self-Injury in Eating Disorders. Non-Suicidal Self-Injury in Eating Disorders
197
214
.
Adam C. Carney. (2013) Efficacy of Quetiapine Off-Label Uses: Data Synthesis. Journal of Psychosocial Nursing and Mental Health Services 51:8, pages 11-18.
Crossref
Crossref
. 2013. Personality Disorders. Personality Disorders
139
157
.
Nathasha Moallem & Lara A. Ray. (2012) Quetiapine improves response inhibition in alcohol dependent patients: A placebo-controlled pilot study. Pharmacology Biochemistry and Behavior 100:3, pages 490-493.
Crossref
Crossref
Silvio Bellino, Paola Bozzatello, Camilla Rinaldi & Filippo Bogetto. (2011) Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability. Depression Research and Treatment 2011, pages 1-7.
Crossref
Crossref
Jutta Stoffers, Birgit A Völlm, Gerta Rücker, Antje Timmer, Nick Huband & Klaus Lieb. (2010) Pharmacological interventions for borderline personality disorder. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Giuliana Mircoli, Sara Bascioni, Chiara Lucarelli & Cesario Bellantuono. (2010) Antipsicotici atipici nel trattamento farmacologico del disturbo borderline di personalità: una revisione sistematica. Quaderni Italiani di Psichiatria 29:2, pages 51-58.
Crossref
Crossref
Jawad Adil. (2018) Antipsychotics and borderline personality
disorder. British Journal of Psychiatry 196:4, pages 332-332.
Crossref
Crossref
Lars Mehlum. (2011) Clinical challenges in the assessment and management of suicidal behaviour in patients with bordeline personality disorder. Epidemiologia e Psichiatria Sociale 18:3, pages 184-190.
Crossref
Crossref
Nurith Amitai & Athina Markou. (2009) Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment. Pharmacology Biochemistry and Behavior 93:3, pages 248-257.
Crossref
Crossref
Silvio Bellino, Erika Paradiso & Filippo Bogetto. (2008) Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder. Psychiatry Research 161:2, pages 206-212.
Crossref
Crossref
Frédérique Van den Eynde, Vesile Senturk, Kris Naudts, Caroline Vogels, Katrien Bernagie, Olivier Thas, Cornelis van Heeringen & Kurt Audenaert. (2008) Efficacy of Quetiapine for Impulsivity and Affective Symptoms in Borderline Personality Disorder. Journal of Clinical Psychopharmacology 28:2, pages 147-155.
Crossref
Crossref
Silvio Bellino, Erika Paradiso & Filippo Bogetto. (2008) Efficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder. CNS Drugs 22:8, pages 671-692.
Crossref
Crossref
Corrine K. Lutz & Jerrold S. Meyer. 2008. Primate Models of Children's Health and Developmental Disabilities. Primate Models of Children's Health and Developmental Disabilities
109
140
.
A. Mobascher, J. Mobascher, C. Schmahl & J. Malevani. (2007) Behandlung der Borderline-Persönlichkeitsstörung mit atypischen AntipsychotikaTreatment of borderline personality disorder with atypical antipsychotic drugs. Der Nervenarzt 78:9, pages 1003-1013.
Crossref
Crossref
Deanna Mercer. (2007) Medications in the treatment of borderline personality disorder 2006. Current Psychiatry Reports 9:1, pages 53-62.
Crossref
Crossref
Carmine Perrella, Dario Carrus, Emilia Costa & Fabrizio Schifano. (2007) Quetiapine for the treatment of borderline personality disorder; an open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:1, pages 158-163.
Crossref
Crossref
Paul J. Markovitz. (2004) Recent Trends in the Pharmacotherapy of Personality Disorders. Journal of Personality Disorders 18:1, pages 90-101.
Crossref
Crossref